세계의 심상성 천포창 시장 보고서(2025년)

Pemphigus vulgaris is a rare autoimmune disorder that causes blistering and sores on the skin and mucous membranes, including the mouth, throat, and genitals. It occurs when the immune system mistakenly targets the proteins that hold skin cells together, leading to the formation of painful blisters. These blisters can rupture easily, resulting in raw, open sores. Pemphigus vulgaris is a chronic condition and can be life-threatening if not treated properly, usually with immunosuppressive medications to regulate the immune system's abnormal response.

The primary methods for diagnosing and treating pemphigus vulgaris include clinical evaluation, skin biopsy, and immunological tests to detect autoantibodies. The condition can affect various age groups, including pediatrics, adults, and geriatrics. Treatment is distributed through several channels, including hospitals, retail pharmacies, and online pharmacies. It is used by various end-users such as hospitals, specialty clinics, research institutes, and others.

The pemphigus vulgaris market research report is one of a series of new reports from The Business Research Company that provides pemphigus vulgaris market statistics, including the pemphigus vulgaris industry global market size, regional shares, competitors with the pemphigus vulgaris market share, detailed pemphigus vulgaris market segments, market trends, and opportunities, and any further data you may need to thrive in the pemphigus vulgaris industry. This pemphigus vulgaris market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pemphigus vulgaris market size has grown strongly in recent years. It will grow from $1.80 billion in 2024 to $1.95 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth observed during the historical period can be attributed to factors such as the increasing adoption of biologic therapies, a rising incidence of genetic predisposition, the growing prevalence of pemphigus vulgaris, the expanding role of biosimilars, and improvements in healthcare infrastructure.

The pemphigus vulgaris market size is expected to see strong growth in the next few years. It will grow to $2.63 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. Looking ahead, the growth in the forecast period is expected to be driven by an increase in clinical trials, advancements in precision medicine, the growth of digital health solutions, higher demand for biologics, and the expanded use of telemedicine. Key trends for the forecast period include advancements in biologic therapies, regulatory approvals, the adoption of combination therapies, progress in personalized medicine, and innovations in oral formulations of biologic therapies.

The increasing prevalence of autoimmune diseases is expected to drive the growth of the pemphigus vulgaris market in the coming years. Autoimmune diseases occur when the immune system mistakenly attacks the body's own healthy cells, tissues, or organs. This rise in prevalence is influenced by genetic factors, environmental triggers, and lifestyle changes. Individuals with a family history of autoimmune diseases are more likely to develop them due to inherited vulnerabilities in their immune system. As autoimmune diseases become more widespread, including conditions such as pemphigus vulgaris, there is a greater demand for advanced therapies to manage these disorders. For instance, according to Mayo Clinic Health System in January 2025, the global incidence and prevalence of autoimmune diseases are both increasing, with annual increases estimated at 19.1% and 12.5%, respectively. As a result, the growing prevalence of autoimmune diseases is fueling the expansion of the pemphigus vulgaris market.

Major companies in the pemphigus vulgaris market are investing in solutions aimed at expanding therapeutic options. These investment solutions involve financial strategies and resources allocated to treatment development, research, and market introduction. For example, in January 2023, the Patient Access Network (PAN) Foundation, a U.S.-based non-profit organization, launched a financial assistance program that offers up to $6,600 annually for eligible pemphigus vulgaris patients. This assistance covers deductibles, copays, and coinsurance costs, with eligibility criteria including treatment for pemphigus vulgaris, Medicare insurance that covers necessary medications, and an income at or below 400% of the federal poverty level. The PAN Foundation also provides transportation assistance and connects patients with support organizations.

In December 2023, PAN Foundation partnered with the International Pemphigus & Pemphigoid Foundation to offer financial aid and support to pemphigus vulgaris patients. Through this partnership, the PAN Foundation continues to provide financial assistance of up to $6,600, along with access to educational resources and support services, aiming to alleviate the financial burden of treatment and improve the quality of life for affected individuals. The International Pemphigus and Pemphigoid Foundation is a U.S.-based non-profit organization that provides resources and solutions for pemphigus vulgaris patients.

Major players in the pemphigus vulgaris market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation.

North America was the largest region in the pemphigus vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pemphigus vulgaris report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pemphigus vulgaris market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pemphigus vulgaris market consists of revenues earned by entities by providing services such as physical therapy, palliative care, patient support groups, psychological support and counseling, and immunosuppressive therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The pemphigus vulgaris market includes sales of skin biopsy kits and serological test kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pemphigus Vulgaris Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pemphigus vulgaris market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pemphigus vulgaris ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pemphigus vulgaris market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnosis And Treatment: Diagnosis; Treatment
• 2) By Population Type: Pediatric; Adults; Geriatric
• 3) By Distribution Channel: Hospitals Pharmacy; Retail Pharmacy; Online Pharmacy
• 4) By End-User: Hospitals; Specialty Clinics; Research Institutes; Other End-Users
• Subsegments:
• 1) By Diagnosis: Clinical Examination; Skin Biopsy; Direct Immunofluorescence; Serological Tests; Polymerase Chain Reaction (PCR)
• 2) By Treatment: Pharmacological Therapy; Non-Pharmacological Therapy
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc; Amgen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pemphigus Vulgaris Market Characteristics

3. Pemphigus Vulgaris Market Trends And Strategies

4. Pemphigus Vulgaris Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pemphigus Vulgaris Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pemphigus Vulgaris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pemphigus Vulgaris Market Growth Rate Analysis
• 5.4. Global Pemphigus Vulgaris Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pemphigus Vulgaris Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pemphigus Vulgaris Total Addressable Market (TAM)

6. Pemphigus Vulgaris Market Segmentation

• 6.1. Global Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Treatment
• 6.2. Global Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric
• Adults
• Geriatric
• 6.3. Global Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.4. Global Pemphigus Vulgaris Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Research Institutes
• Other End-Users
• 6.5. Global Pemphigus Vulgaris Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Examination
• Skin Biopsy
• Direct Immunofluorescence
• Serological Tests
• Polymerase Chain Reaction (PCR)
• 6.6. Global Pemphigus Vulgaris Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacological Therapy
• Non-Pharmacological Therapy

7. Pemphigus Vulgaris Market Regional And Country Analysis

• 7.1. Global Pemphigus Vulgaris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pemphigus Vulgaris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pemphigus Vulgaris Market

• 8.1. Asia-Pacific Pemphigus Vulgaris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pemphigus Vulgaris Market

• 9.1. China Pemphigus Vulgaris Market Overview
• 9.2. China Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pemphigus Vulgaris Market

• 10.1. India Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pemphigus Vulgaris Market

• 11.1. Japan Pemphigus Vulgaris Market Overview
• 11.2. Japan Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pemphigus Vulgaris Market

• 12.1. Australia Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pemphigus Vulgaris Market

• 13.1. Indonesia Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pemphigus Vulgaris Market

• 14.1. South Korea Pemphigus Vulgaris Market Overview
• 14.2. South Korea Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pemphigus Vulgaris Market

• 15.1. Western Europe Pemphigus Vulgaris Market Overview
• 15.2. Western Europe Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pemphigus Vulgaris Market

• 16.1. UK Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pemphigus Vulgaris Market

• 17.1. Germany Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pemphigus Vulgaris Market

• 18.1. France Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pemphigus Vulgaris Market

• 19.1. Italy Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pemphigus Vulgaris Market

• 20.1. Spain Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pemphigus Vulgaris Market

• 21.1. Eastern Europe Pemphigus Vulgaris Market Overview
• 21.2. Eastern Europe Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pemphigus Vulgaris Market

• 22.1. Russia Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pemphigus Vulgaris Market

• 23.1. North America Pemphigus Vulgaris Market Overview
• 23.2. North America Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pemphigus Vulgaris Market

• 24.1. USA Pemphigus Vulgaris Market Overview
• 24.2. USA Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pemphigus Vulgaris Market

• 25.1. Canada Pemphigus Vulgaris Market Overview
• 25.2. Canada Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pemphigus Vulgaris Market

• 26.1. South America Pemphigus Vulgaris Market Overview
• 26.2. South America Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pemphigus Vulgaris Market

• 27.1. Brazil Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pemphigus Vulgaris Market

• 28.1. Middle East Pemphigus Vulgaris Market Overview
• 28.2. Middle East Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pemphigus Vulgaris Market

• 29.1. Africa Pemphigus Vulgaris Market Overview
• 29.2. Africa Pemphigus Vulgaris Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pemphigus Vulgaris Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pemphigus Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pemphigus Vulgaris Market Competitive Landscape And Company Profiles

• 30.1. Pemphigus Vulgaris Market Competitive Landscape
• 30.2. Pemphigus Vulgaris Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pemphigus Vulgaris Market Other Major And Innovative Companies

• 31.1. Sanofi S.A
• 31.2. Biogen Inc.
• 31.3. Genentech
• 31.4. Genmab A/S
• 31.5. argenx SE
• 31.6. Daewoong Pharmaceutical Co. Ltd.
• 31.7. HanAll Biopharma Co. Ltd.
• 31.8. Artiva Biotherapeutics
• 31.9. Cabaletta Bio Inc.
• 31.10. SinoMab BioScience Limited
• 31.11. Topas Therapeutics GmbH
• 31.12. Principia Biopharma Inc.
• 31.13. Serpin Pharma LLC
• 31.14. Syntimmune Inc.
• 31.15. International Pemphigus & Pemphigoid Foundation

32. Global Pemphigus Vulgaris Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pemphigus Vulgaris Market

34. Recent Developments In The Pemphigus Vulgaris Market

35. Pemphigus Vulgaris Market High Potential Countries, Segments and Strategies

• 35.1 Pemphigus Vulgaris Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pemphigus Vulgaris Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pemphigus Vulgaris Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer